on DBV TECHNOLOGIES (EPA:DBV)
DBV Technologies to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
Châtillon, France, June 5, 2024 — DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq: DBVT), a clinical-stage biopharmaceutical company, announced its participation in the 45th Annual Goldman Sachs Global Healthcare Conference.
Daniel Tassé, CEO of DBV Technologies, will represent the company in a fireside chat on June 10th at 8:00 am EDT. He will also engage in one-on-one meetings with investors.
The fireside chat will be webcast live and can be accessed on DBV Technologies' Investors website. A replay will be available for 90 days after the event.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all DBV TECHNOLOGIES news